08th May 2024 – Samsung Electronics announced on Wednesday that its medical equipment unit, Samsung Medison, has acquired the French AI medtech startup Sonio, as part of its initiative to expand its AI-powered healthcare solutions. Through a share purchase agreement, Samsung Medison will gain access to Sonio’s expertise in AI development for diagnostic reporting in obstetrics and gynaecology ultrasound.
Founded in 2020, Sonio specializes in AI-powered prenatal screening solutions, with its key product, Sonio Detect, gaining FDA approval in 2023. The acquisition will enable Samsung Medison to enhance its medical AI solutions with Sonio’s technology and talent pool in Europe.
This move reflects Samsung’s commitment to advancing healthcare technology through strategic acquisitions, positioning the company to offer innovative solutions in obstetrics and gynaecology ultrasound diagnostics.
Conclusion
Samsung’s acquisition of Sonio underscores its dedication to leveraging AI technology to enhance healthcare solutions. By integrating Sonio’s AI capabilities, Samsung Medison aims to further its impact in the medical field, benefiting patients and healthcare professionals alike.
Source:Link
